Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
clinical trials
eli lilly
5
×
fda
5
×
life sciences
national blog main
amgen
boston blog main
boston top stories
national top stories
san francisco blog main
blueprint medicines
calcitonin gene-related peptide
chronic migraine
episodic migraine
europe blog main
indiana blog main
indiana top stories
migraine
national
new york blog main
san francisco top stories
teva pharmaceutical
abbvie
alder biopharmaceuticals
allergan
avapritinib
biohaven
black diamond therapeutics
bladder cancer
boston
boulder/denver blog main
boulder/denver top stories
cancer
cancer drugs
cgpr
cstone pharmaceuticals
david rind
deals
deciphera pharmaceuticals
What
medicines
5
×
drug
fda
new
approval
class
migraine
approved
cancer
developed
nod
pain
starts
wins
won
adults
allergan
amgen
announced
biotech
black
blueprint
candidate
candidates
clinic
companies
currently
decision
diamond
eli
eluded
gets
head
headache
hopes
ipo
late
lead
leading
lilly
Language
unset
Current search:
medicines
×
fda
×
" eli lilly "
×
@xconomy.com
3 years ago
Roche, Blueprint Medicines Team Up Again in $775M RET Cancer Drug Pact
@xconomy.com
4 years ago
Black Diamond Lines Up IPO as Lead Cancer Drug Nears Clinic
@xconomy.com
4 years ago
Allergan Wins FDA Nod for First Migraine Pill in New Class of Medicines
@xconomy.com
5 years ago
Eli Lilly Migraine Drug Approved, the Third in New Class of Medicines
@xconomy.com
5 years ago
Amgen Migraine Drug Gets FDA Nod, First in New Class of Medicines